logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Liu Qiangdong said he had made an appointment with Wang Xing but couldn't meet him.

date
16/09/2025
On September 16th, at the JD Wine Tasting event, JD founder Liu Qiangdong was asked if he had met with Meituan CEO Wang Xing later. He said he had made an appointment with Wang Xing before, but Wang Xing said he was busy with a "war" with Cheng Wei outside. His friend Yao Jinbo suggested inviting Meituan's Senior Vice President Wang Puzhong, but Wang Puzhong said "if the boss doesn't go, I dare not go." In the end, the meeting never took place.
Latest
3 m ago
U.S. Department of Energy: Approves sixth loan disbursement for restart of Palisades nuclear power plant.
5 m ago
US stock unusual movement | Nio (NIO.US) rises nearly 3%, the all-new ES8 is about to be officially launched.
6 m ago
Relay Company announced plans to build a $5 billion production facility in Goochland County, west of Richmond, Virginia. The new facility will be the company's first fully integrated active pharmaceutical ingredient and drug product manufacturing base specifically designed to service emerging bioconjugate platforms and monoclonal antibody product lines. The production facility is expected to be completed within the next five years.
7 m ago
US stocks fluctuate | Promotion of weight loss drugs under Hims & Hers Health receives FDA warning Hims & Hers Health(HIMS.US) drops more than 7%
9 m ago
Wang Yi Meets with Cambodian Deputy Prime Minister Son Soubert
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.